Alkemi’s approach is built on an Evidence-Centered Value and Access Strategy designed for life sciences leaders under pressure. Whether you’re preparing for launch or facing an immediate access threat or, our proprietary systems deliver clarity, alignment, and speed in 90 days or less.
In a shifting access landscape, delay is the wrong decision. Our process is designed to:
Move faster than the access threat.
Align cross-functional teams under pressure.
Build decisive cases with relevant evidence today, not perfect data tomorrow.
The ideal choice for when access or evidence is already under threat. This 4-step system is proven to address and resolve acute threats in 90 days. You’ll achieve fast resolution, stronger positioning, and renewed payer confidence.
Map the decision network, pinpoint policy shifts, competitive moves, and evidence gaps.
Output: Threat Map + Decision Network + “What Changed” Brief
Validate what each stakeholder needs to say “yes” now and identify proof gaps.
Output: Priority Signals + Objection List + Proof Requirements
Connect your evidence to current decision criteria, pre-empt objections, and align internal teams.
Output: Decisive Case + Counter-Arguments + Internal Alignment Kit
.avif)
Remove prescribing and formulary friction. Build pull-through mechanisms for rapid uptake.
Output: Adoption Playbook + Pull-Through Plan + Day-0 Rollout Brief
A strategic, defensive plan for when you want to protect a launch before threats emerge. This proactive 4-step defense system is meant to support “access immunity” and prepare you for a threat-ready launch with ≤10-day response capability.
Identify policy, payer, and competitor risk scenarios across the 18-month launch window.
Output: Threat Map + Risk Timeline + Vulnerability Assessment
Build pre-approved evidence and countermeasures for each risk scenario.
Output: Response Playbooks + Pre-Approved Messages + Evidence Bank
Establish global and regional decision trees and escalation pathways for real-time coordination.
Output: Alignment Framework + Team Coordination Kit
Create “easy-yes” pathways and launch pull-through tactics.
Output: Adoption Playbook + Launch Acceleration Kit
Innovative treatments fail commercially because of avoidable mistakes
Missed opportunities to build the right evidence
Focusing on the wrong decision-makers
Reacting too slowly to competitive, policy, or payer shifts
Markets move fast, especially in disruptive therapeutic areas with high unmet need. But when value and access strategies can’t keep pace, even breakthrough innovations lose momentum.
That’s why we built a six-part framework for evidence, value, and access planning—helping biotech teams anticipate threats, align stakeholders, and secure lasting access.
Alkemi was founded by industry veterans who saw too many preventable access crises. Treatments lost ground not from weak science, but from delays, siloed plans, and slow consultants.
We built our systems to change that. The result?
Policy reversals contained in 6 weeks.
Competitor evidence neutralized in 45 days.
Teams aligned and ready when it mattered most.
“Really appreciate your support - as you know I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months.”
![[headshot] image of customer (for a home inspector)](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c5aee875a9e30534dab_da918c69-68ea-42eb-8ad0-fd4f176193a5.avif)
“When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'. That was my goal for this project so sounds like we achieved it.”
![image of successful businesses [headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59ad68004ea9ddd6b4_c1cd2a51-1f06-45cb-9a13-4199a77f0015.avif)
“In a record 3.5 days, guidelines have been updated to include [treatment]. Woohoo!!”
![[headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59dcf34a6442165770_122204b6-f407-479f-9bb7-84c323ad8f65.avif)
"When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'.
“I wanted to reach out and tell you that the publication is getting GREAT reception from senior BU leadership across the company. Thank you again for your and Alkemi’s support on this project!”
"Thanks to the whole team involved in staging this Advisory Council. I was fortunate to be able to attend and here the insights from the council members firsthand. The report provides an excellent summary."
"Really appreciate your support - as you know I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months. Thank you so much - this is an important event for our team, companies and clients - and you really helped make it a success. I heard 3 groups leave with ambitions to up their game - and they’re the 3 that need to do it the most - so the message landed as well."
Schedule a confidential strategy call and see how Alkemi’s process moves you from threat to resolution in 90 days or less.